JASCAYD 9 mg,18 mg Nerandomilast Tablets Instructions
JASCAYD 9 mg,18 mg Nerandomilast Tablets Specifications Dosage Forms: Tablets: 9 mg and 18 mg Indications: Idiopathic Pulmonary Fibrosis, Progressive Pulmonary Fibrosis Contraindications: None Adverse Reactions: Common reactions include diarrhea, COVID-19, upper respiratory tract infection, depression,weight decreased, decreased appetite, nausea,…